AstraZeneca announced results from a new analysis of its landmark CVD-REAL study, the first large real-world evidence study of its...
Oral Psoriatic Arthritis TriaL (OPAL) studies, Broaden and Beyond, were presented at the 2016 ACR/ARHP Annual Meeting (November 11-16, Washington,...
Ferring Pharmaceuticals announced that the National Institute for Health and Care Excellence (NICE) has recommended Firmagon (degarelix) for a group...